Rehman Khalid, Arif Nauman, Jawad Muhammad, Muhammad Ali
Khalid Rehman, PhD, MPH, MBBS, Institute of Public Health & Social Sciences, Khyber Medical University, Peshawar, Pakistan.
Nauman Arif, Pharm-D, MSc, Institute of Public Health & Social Sciences, Khyber Medical University, Peshawar, Pakistan.
Pak J Med Sci. 2023 Mar-Apr;39(2):553-556. doi: 10.12669/pjms.39.2.6051.
BACKGROUND & OBJECTIVE: COVID-19 vaccine has become available within a record time but mere availability will not control the pandemic. High vaccine acceptance is required. The objective was to determine COVID-19 vaccine acceptance and its associated factors among Pakistani population.
An online survey using google form, was conducted from January 31 to February 9, 2021 before the start of the mass vaccination in Pakistan. The questionnaire had questions about demographics plus vaccine hesitancy. We received a total of 1156 responses. Data was analyzed using STATA version 14. We employed descriptive statistics and chi square test.
A total of 1156 responses were received. 65% were male and 35% female. Only 6% were uneducated. Thirty percent had tested positive for COVID-19 earlier. Forty-six percent of the respondents would take (acceptance) a vaccine if available. Forty-eight percent and 45% were confident in using USA/UK and Chinese vaccine respectively. Gender and marital status was statistically significantly associated with vaccine acceptance. Concerns about the side effects were 55% while for efficacy it was 69%. Twenty-three percent were concerned about the permissibility of the vaccine on religious grounds.
Gender and marital status was significantly associated with vaccine acceptance. Forty-six percent respondents were willing to take the vaccine. Among the vaccine hesitant group, respondents were worried about the side effects, safety and religious permissibility of vaccine. Policy makers and all the relevant stakeholders should consider low vaccine acceptance as a major bottleneck and should devise strategies to address this major issue in the fight against COVID-19.
新冠疫苗在创纪录的时间内问世,但仅疫苗可用并不能控制疫情。需要民众对疫苗有较高的接受度。本研究旨在确定巴基斯坦人群对新冠疫苗的接受度及其相关因素。
在巴基斯坦大规模疫苗接种开始前,于2021年1月31日至2月9日通过谷歌表单进行了一项在线调查。问卷包含有关人口统计学以及疫苗犹豫情况的问题。我们共收到1156份回复。使用STATA 14版软件对数据进行分析。我们采用了描述性统计和卡方检验。
共收到1156份回复。男性占65%,女性占35%。未受过教育的仅占6%。30%的人曾感染新冠病毒且检测呈阳性。46%的受访者表示如果有疫苗会接种(接受)。分别有48%和45%的受访者对使用美国/英国和中国疫苗有信心。性别和婚姻状况与疫苗接受度在统计学上显著相关。对副作用的担忧占55%,对有效性的担忧占69%。23%的人担心疫苗在宗教方面是否允许使用。
性别和婚姻状况与疫苗接受度显著相关。46%的受访者愿意接种疫苗。在对疫苗持犹豫态度的人群中,受访者担心疫苗的副作用、安全性以及宗教方面的可接受性。政策制定者和所有相关利益攸关方应将疫苗接受度低视为一个主要瓶颈,并应制定策略来解决抗击新冠疫情中的这一重大问题。